Cargando…

Thiazolidinediones and bone fractures

Detalles Bibliográficos
Autores principales:	Kaku, Kohei, Hashiramoto, Mitsuru
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2011
Materias:	Commentaries
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4019301/ https://www.ncbi.nlm.nih.gov/pubmed/24843512 http://dx.doi.org/10.1111/j.2040-1124.2011.00142.x

Ejemplares similares

Sirtuin 1 as a key player of ‘metabolic memory’
por: Hashiramoto, Mitsuru, et al.
Publicado: (2013)

Remission of hyperglycemia after withdrawal of oral antidiabetic drugs in Japanese patients with early‐stage type 2 diabetes
por: Hirukawa, Hidenori, et al.
Publicado: (2018)

Risk of Fracture with Thiazolidinediones: Disease or Drugs?
por: Bazelier, Marloes T., et al.
Publicado: (2012)

Thiazolidinediones on PPARγ: The Roles in Bone Remodeling
por: Wei, Wei, et al.
Publicado: (2011)

Risk of Fracture with Thiazolidinediones: An Individual Patient Data Meta-Analysis
por: Bazelier, Marloes T., et al.
Publicado: (2013)

Glycemic Control with Thiazolidinedione Is Associated with Fracture of T2DM Patients
por: Chen, Hsin-Hung, et al.
Publicado: (2015)

Chemotherapy and Chemoprevention by Thiazolidinediones
por: Fröhlich, Eleonore, et al.
Publicado: (2015)

Bone Loss in Diabetes: Use of Antidiabetic Thiazolidinediones and Secondary Osteoporosis
por: Lecka-Czernik, Beata
Publicado: (2010)

Thiazolidinediones and Edema: Recent Advances in the Pathogenesis of Thiazolidinediones-Induced Renal Sodium Retention
por: Horita, Shoko, et al.
Publicado: (2015)

Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones
por: Benova, Andrea, et al.
Publicado: (2022)

Molecular mechanism by which pioglitazone preserves pancreatic β-cells in obese diabetic mice: evidence for acute and chronic actions as a PPARγ agonist
por: Kanda, Yukiko, et al.
Publicado: (2010)

Controversy about the relationship between sulfonylurea use and cardiovascular events and mortality
por: Shimoda, Masashi, et al.
Publicado: (2016)

Clinical relevance of dual agonist of glucagon and glucagon‐like peptide‐1 receptors to achieve functional restoration of first‐ and second‐phase insulin secretion
por: Kimura, Tomohiko, et al.
Publicado: (2022)

The Risk of Fractures Associated with Thiazolidinediones: A Self-controlled Case-Series Study
por: Douglas, Ian J., et al.
Publicado: (2009)

Thiazolidinediones: the Forgotten Diabetes Medications
por: Lebovitz, Harold E.
Publicado: (2019)

Azelnidipine, but not amlodipine, reduces urinary albumin excretion and carotid atherosclerosis in subjects with type 2 diabetes: blood pressure control with olmesartan and azelnidipine in Type 2 diabetes (BOAT2 study)
por: Tawaramoto, Kazuhito, et al.
Publicado: (2015)

Effects of Lobeglitazone, a New Thiazolidinedione, on Osteoblastogenesis and Bone Mineral Density in Mice
por: Kim, Kyoung Min, et al.
Publicado: (2017)

Thiazolidinedione induced thyroid associated orbitopathy
por: Lee, Seongmu, et al.
Publicado: (2007)

Therapeutic Actions of the Thiazolidinediones in Alzheimer's Disease
por: Pérez, María José, et al.
Publicado: (2015)

Thiazolidinediones are partially effective bitter blockers
por: Nguyen, Ha, et al.
Publicado: (2023)

Case of newly onset type 1 diabetes after highly active antiretroviral therapy against HIV infection
por: Kamei, Shinji, et al.
Publicado: (2015)

Increased Circulating Adiponectin in Response to Thiazolidinediones: Investigating the Role of Bone Marrow Adipose Tissue
por: Sulston, Richard J., et al.
Publicado: (2016)

Comparison of the Effects of Metformin and Thiazolidinediones on Bone Metabolism: A Systematic Review and Meta-Analysis
por: Chen, Ru-Dong, et al.
Publicado: (2023)

Use of thiazolidinediones and risk of hip fracture in old people in a case–control study in Taiwan
por: Lin, Hsien-Feng, et al.
Publicado: (2017)

Muscle: a source of progenitor cells for bone fracture healing
por: Henrotin, Yves
Publicado: (2011)

T cells heal bone fractures with help from the gut microbiome
por: Aurora, Rajeev, et al.
Publicado: (2023)

Type 2 Diabetes: Uses of thiazolidinediones and insulin
por: T. Bloomgarden, Zachary
Publicado: (2011)

Thiazolidinediones and Fertility in Polycystic Ovary Syndrome (PCOS)
por: Froment, Pascal, et al.
Publicado: (2006)

Thiazolidinediones and Cardiovascular Risk — A Question of Balance
por: Erdmann, Erland, et al.
Publicado: (2009)

Factors Associated with Results and Conclusions of Trials of Thiazolidinediones
por: Rattinger, Gail, et al.
Publicado: (2009)

Biological potential of thiazolidinedione derivatives of synthetic origin
por: Sucheta, et al.
Publicado: (2017)

Effects of Thiazolidinedione and New Antidiabetic Agents on Stroke
por: Ahn, Chang Ho, et al.
Publicado: (2019)

Oldies but Goodies: Thiazolidinedione as an Insulin Sensitizer with Cardioprotection
por: Cho, Eun-Hee
Publicado: (2022)

Potential Therapeutic Effects of Thiazolidinedione on Malignant Glioma
por: Sheu, Meei-Ling, et al.
Publicado: (2022)

Clinical Management of Nonalcoholic Steatohepatitis (NASH) With the Use of Thiazolidinediones and the Additive Effect of Thiazolidinediones and a GLP-1 Agonist: Case Series
por: Rojas Ortiz, Valentina, et al.
Publicado: (2021)

No pain, no gain: Will migraine therapies increase bone loss and impair fracture healing?
por: Kacena, Melissa A., et al.
Publicado: (2020)

Renal and Vascular Mechanisms of Thiazolidinedione-Induced Fluid Retention
por: Yang, Tianxin, et al.
Publicado: (2008)

Beneficial Effects of Thiazolidinediones on Diabetic Nephropathy in OLETF Rats
por: Lee, Mi Young, et al.
Publicado: (2007)

Redefining the role of thiazolidinediones in the management of type 2 diabetes
por: Barnett, Anthony H
Publicado: (2009)

Molecular Mechanism of Thiazolidinedione-Mediated Inhibitory Effects on Osteoclastogenesis
por: Zhao, Dongfeng, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_gr1oo2durat6vvb2k4q938eiab